✦ LIBER ✦

Serum procollagen type III peptide in chronic hepatitis B treated with recombinant interferon alfa-2b

✍ Scribed by Velosa, J; Serejo, F; Saraiva, A; Marinho, R; Ramalho, F; de Moura, M Cameiro

Book ID: 123358533
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 70 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)90203-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum procollagen type III peptide in ch

Serum procollagen type III peptide in chronic hepatitis B

✍ G. Giustina; G. Fattovich; M. De Paoli; M. Guido; S. Favarato; M. Rugge; A. Albe 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 403 KB

Serum procollagen type III peptide (P II

Serum procollagen type III peptide (P III NP) in chronic NANB hepatitis treated with 2b interferon (IFN): Its correlation with histological activity

✍ Serejo, F.; Costa, A.; Marinho, R.; Raimundo, M.; Ramalho, F.; Velosa, J.; Bapti 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant alfa interferon 2B

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Long-term recombinant interferon alfa-2b

Long-term recombinant interferon alfa-2b therapy in patients with chronic hepatitis B

✍ Picciotto, A; Lapertosa, G; Valle, F; Varagona, G; Celle, G 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Recombinant interferon alfa-2b following

Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis

✍ Perez, V.; Tanno, H.; Villamil, F.; Fay, O. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Long-term decrease in serum N-terminal p

Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa

✍ Takeaki Suou; Keiko Hosho; Yukihiro Kishimoto; Yasushi Horie; Hironaka Kawasaki 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

To evaluate the effect of interferon alfa (EN-a) on the hepatic extracellular matrix, we investigated the changes in serum N-terminal propeptide of type I11 procollagen during and after 4 months of INF-ru treatment in 178 treated and 45 nontreated patients with chronic hepatitis C. Serum pretreatmen